home / stock / otlk / otlk articles

OTLK Articles, Outlook Therapeutics Inc. - From 12/16/23

Stock Information
Company Name: Outlook Therapeutics Inc.
Stock Symbol: OTLK
Market: NASDAQ
Menu
OTLK OTLK Quote OTLK Short OTLK News OTLK Articles OTLK Message Board
Get OTLK Alerts

News, Short Squeeze, Breakout and More Instantly...
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Outlook Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – OTLK | Benzinga

NEW YORK, Dec. 16, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outlook...
OTLK STOCK ALERT: Robbins LLP Reminds Investors of January 2, 2024, Lead Plaintiff Deadline in the Class Action Filed Against Outlook Therapeutics, Inc. | Benzinga

SAN DIEGO, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action lawsuit on behalf of persons...

ROSEN, A LONGSTANDING LAW FIRM, Encourages Outlook Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – OTLK | Benzinga

NEW YORK, Dec. 12, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outlook...

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Outlook Therapeutics, Inc. (OTLK) Investors and Encourages Investors to Contact the Firm Before January 2, 2024 | Benzinga

NEW YORK, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S....
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OTLK | Benzinga

NEW YORK, Dec. 08, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outlook...

OUTLOOK INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Outlook To Contact Him Directly To Discuss Their Options | Benzinga

If you suffered losses exceeding $50,000 investing in Outlook securities between December 29, 2022 and August 29, 2023 and would like to discuss y...

Outlook Therapeutics® Announces Strategic Organizational Realignment | Benzinga

Realignment focused on supporting ONS-5010 U.S. and EU regulatory and commercial priorities Continued progress toward commencement of additional ...
DEADLINE ALERT: Bernstein Liebhard LLP Reminds Outlook Therapeutics, Inc. Investors of Upcoming Deadline | Benzinga

NEW YORK, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Outlook Therapeutics, Inc. (NASDAQ:OTLK)?...

OUTLOOK SHAREHOLDER ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Outlook To Contact Him Directly To Discuss Their Options | Benzinga

If you suffered losses exceeding $50,000 investing in Outlook securities between December 29, 2022 and August 29, 2023 and would like to discuss y...

ROSEN, LEADING INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OTLK | Benzinga

NEW YORK, Dec. 01, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outlook...
Previous 10 Next 10